233 related articles for article (PubMed ID: 21726209)
1. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage.
Chen SH; Wu HM; Ossola B; Schendzielorz N; Wilson BC; Chu CH; Chen SL; Wang Q; Zhang D; Qian L; Li X; Hong JS; Lu RB
Br J Pharmacol; 2012 Jan; 165(2):494-505. PubMed ID: 21726209
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons.
Wu X; Chen PS; Dallas S; Wilson B; Block ML; Wang CC; Kinyamu H; Lu N; Gao X; Leng Y; Chuang DM; Zhang W; Lu RB; Hong JS
Int J Neuropsychopharmacol; 2008 Dec; 11(8):1123-34. PubMed ID: 18611290
[TBL] [Abstract][Full Text] [Related]
3. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo.
Dincman TA; Beare JE; Ohri SS; Gallo V; Hetman M; Whittemore SR
Int J Dev Neurosci; 2016 Nov; 54():53-61. PubMed ID: 27587342
[TBL] [Abstract][Full Text] [Related]
5. Targeting cyclin D3/CDK6 activity for treatment of Parkinson's disease.
Alquézar C; Barrio E; Esteras N; de la Encarnación A; Bartolomé F; Molina JA; Martín-Requero Á
J Neurochem; 2015 Jun; 133(6):886-97. PubMed ID: 25689470
[TBL] [Abstract][Full Text] [Related]
6. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
7. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.
Wu HM; Tzeng NS; Qian L; Wei SJ; Hu X; Chen SH; Rawls SM; Flood P; Hong JS; Lu RB
Neuropsychopharmacology; 2009 Sep; 34(10):2344-57. PubMed ID: 19536110
[TBL] [Abstract][Full Text] [Related]
8. Induction of glial cell line-derived neurotrophic factor by the squamosamide derivative FLZ in astroglia has neuroprotective effects on dopaminergic neurons.
Bao XQ; Wang L; Yang HY; Hou LY; Wang QS; Zhang D
Brain Res Bull; 2020 Jan; 154():32-42. PubMed ID: 31669104
[TBL] [Abstract][Full Text] [Related]
9. Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition.
Kidd SK; Schneider JS
Brain Res; 2010 Oct; 1354():172-8. PubMed ID: 20654591
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
11. Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.
Collins LM; Adriaanse LJ; Theratile SD; Hegarty SV; Sullivan AM; O'Keeffe GW
Mol Neurobiol; 2015; 51(3):1432-42. PubMed ID: 25065734
[TBL] [Abstract][Full Text] [Related]
12. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
[TBL] [Abstract][Full Text] [Related]
13. Estrogen protects against dopamine neuron toxicity in primary mesencephalic cultures through an indirect P13K/Akt mediated astrocyte pathway.
Bains M; Roberts JL
Neurosci Lett; 2016 Jan; 610():79-85. PubMed ID: 26520464
[TBL] [Abstract][Full Text] [Related]
14. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
Mazzocchi M; Goulding SR; Morales-Prieto N; Foley T; Collins LM; Sullivan AM; O'Keeffe GW
Brain Behav Immun; 2022 May; 102():151-160. PubMed ID: 35217173
[TBL] [Abstract][Full Text] [Related]
15. The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
Duncan HF; Smith AJ; Fleming GJ; Partridge NC; Shimizu E; Moran GP; Cooper PR
J Cell Physiol; 2016 Apr; 231(4):798-816. PubMed ID: 26264761
[TBL] [Abstract][Full Text] [Related]
16. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.
Wang Y; Wang X; Liu L; Wang X
Neurosci Lett; 2009 Dec; 467(3):212-6. PubMed ID: 19835929
[TBL] [Abstract][Full Text] [Related]
17. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
18. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
19. Culture of Rat Mesencephalic Dopaminergic Neurons and Application to Neurotoxic and Neuroprotective Agents.
Skaper SD; Barbierato M; Ferrari V; Zusso M; Facci L
Methods Mol Biol; 2018; 1727():107-118. PubMed ID: 29222776
[TBL] [Abstract][Full Text] [Related]
20. Mechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor.
Shukla S; Shariat-Madar Z; Walker LA; Tekwani BL
Mol Cell Neurosci; 2016 Dec; 77():11-20. PubMed ID: 27678157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
